You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Gastroenterology

European EoE Day 2024 | May 22

In recognition of European EoE Day, ADVENT is providing medical education resources to increase awareness of eosinophilic esophagitis (EoE).

Arjan Bredenoord
Evan Dellon
MD, PhD
Arjan Bredenoord +1 more
Past event
22May2024

Learning objectives

  • Recognize the challenges associated with identifying EoE and the consequences of delayed diagnosis on disease progression
  • Understand the importance of assessing multiple disease domains beyond patient symptoms alone in clinical management of EoE

Description

In recognition of European EoE Day, ADVENT will be working to increase awareness of eosinophilic esophagitis (EoE) by providing medical education resources. Discover more about the latest advances in the science of type 2 inflammation and explore how the latest scientific advances may help clinicians improve the quality of life of their patients with EoE. 

Tags
quality of lifemultiple disease dimensionsdisease progressionsymptoms
MAT-GLB-2401309 - 1.0 - 04/2024; MAT-US-2403359 v1.0 - P Exp. Date: 04/05/2026

Speakers

Gastroenterology
MD, PhD

Arjan Bredenoord

Professor of Neurogastroenterology & Motility | University of Amsterdam, Netherlands; Consultant Gastroenterologist | Amsterdam University Medical Centers

Gastroenterology
MD, MPH

Evan Dellon

Professor of Medicine and Adjunct Professor of Epidemiology | University of North Carolina School of Medicine, Chapel Hill, United States

Related resources

Importance of Assessing Key Disease Domains in EoE Infographic
Gastroenterology
Infographic

Importance of Assessing Key Disease Domains in EoE Infographic

Importance of Assessing Multiple Disease Domains in EoE
Gastroenterology
expert video

Importance of Assessing Multiple Disease Domains in EoE

EoE Burden and Pathophysiology of Type 2 Inflammation
Gastroenterology
videoanimation

EoE Burden and Pathophysiology of Type 2 Inflammation

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region